Virtus ETF Advisers’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-98,218
Closed -$435K 472
2024
Q4
$435K Buy
98,218
+43,143
+78% +$191K 0.18% 187
2024
Q3
$227K Hold
55,075
0.11% 244
2024
Q2
$359K Buy
55,075
+21,798
+66% +$142K 0.18% 190
2024
Q1
$290K Buy
33,277
+4,788
+17% +$41.7K 0.15% 228
2023
Q4
$326K Buy
28,489
+951
+3% +$10.9K 0.21% 209
2023
Q3
$265K Sell
27,538
-3,559
-11% -$34.3K 0.16% 217
2023
Q2
$331K Buy
31,097
+6,259
+25% +$66.6K 0.2% 175
2023
Q1
$261K Buy
24,838
+439
+2% +$4.62K 0.14% 274
2022
Q4
$302K Buy
24,399
+3,829
+19% +$47.4K 0.16% 265
2022
Q3
$213K Buy
20,570
+303
+1% +$3.14K 0.08% 314
2022
Q2
$234K Sell
20,267
-13,795
-40% -$159K 0.09% 311
2022
Q1
$428K Hold
34,062
0.19% 145
2021
Q4
$397K Sell
34,062
-6,633
-16% -$77.3K 0.15% 153
2021
Q3
$531K Sell
40,695
-3,726
-8% -$48.6K 0.23% 129
2021
Q2
$572K Sell
44,421
-6,890
-13% -$88.7K 0.24% 116
2021
Q1
$574K Buy
51,311
+1,403
+3% +$15.7K 0.24% 133
2020
Q4
$568K Sell
49,908
-14,038
-22% -$160K 0.24% 127
2020
Q3
$575K Buy
63,946
+5,386
+9% +$48.4K 0.3% 117
2020
Q2
$604K Buy
58,560
+12,557
+27% +$130K 0.29% 118
2020
Q1
$464K Sell
46,003
-3,882
-8% -$39.2K 0.19% 177
2019
Q4
$664K Sell
49,885
-16,931
-25% -$225K 0.11% 162
2019
Q3
$574K Sell
66,816
-11,244
-14% -$96.6K 0.12% 177
2019
Q2
$854K Sell
78,060
-4,100
-5% -$44.9K 0.18% 167
2019
Q1
$931K Buy
82,160
+19,091
+30% +$216K 1.98% 12
2018
Q4
$547K Buy
63,069
+12,766
+25% +$111K 0.09% 70
2018
Q3
$778K Buy
50,303
+3,390
+7% +$52.4K 0.08% 65
2018
Q2
$751K Sell
46,913
-23,550
-33% -$377K 0.66% 70
2018
Q1
$911K Sell
70,463
-4,162
-6% -$53.8K 0.79% 57
2017
Q4
$937K Buy
74,625
+4,960
+7% +$62.3K 1.18% 37
2017
Q3
$920K Hold
69,665
0.12% 66
2017
Q2
$1.1M Sell
69,665
-9,330
-12% -$148K 0.16% 48
2017
Q1
$1.13M Buy
78,995
+7,596
+11% +$109K 0.2% 56
2016
Q4
$914K Buy
71,399
+13,643
+24% +$175K 0.27% 67
2016
Q3
$768K Buy
57,756
+7,277
+14% +$96.8K 0.37% 46
2016
Q2
$553K Sell
50,479
-13,744
-21% -$151K 0.41% 35
2016
Q1
$588K Buy
+64,223
New +$588K 0.81% 27